Myovant Sciences Ltd. (MYOV) NEW YORK STOCK EXCHANGE INC.

$26.88 -0.01 (-0.04%)

Market Cap: $2.61B

As of 02/03/23 04:00 PM EST. Market closed.

(MYOV)

Myovant Sciences Ltd. (MYOV) NEW YORK STOCK EXCHANGE INC.

$26.88 -0.01 (-0.04%)

Market Cap: $2.61B

As of 02/03/23 04:00 PM EST. Market closed.

Myovant Sciences aspires to redefine care for women and for men through purpose-driven science, empowering medicines, and transformative advocacy. Myovant Sciences has one FDA-approved medicine, ORGOVYX™ (relugolix), for adult patients with advanced prostate cancer. Its lead product candidate, relugolix combination tablet (relugolix 40 mg, estradiol 1.0 mg, and norethindrone acetate 0.5 mg), is ... read more

Myovant Sciences aspires to redefine care for women and for men through purpose-driven science, empowering medicines, and transformative advocacy. Myovant Sciences has one FDA-approved medicine, ORGOVYX™ (relugolix), for adult patients with advanced prostate cancer. Its lead product candidate, relugolix combination tablet (relugolix 40 mg, estradiol 1.0 mg, and norethindrone acetate 0.5 mg), is under regulatory review in Europe and the U.S. for women with uterine fibroids and is under development for women with endometriosis. Myovant Sciences is also developing MVT-602, an oligopeptide kisspeptin-1 receptor agonist, which has completed a Phase 2a study for female infertility as part of assisted reproduction. Sumitovant Biopharma, Ltd., a wholly owned subsidiary of Sumitomo Dainippon Pharma Co., Ltd., is its majority shareholder. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Address
.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
KEY STATS
Open
$26.89
Previous Close
$26.89
Days Range
$26.87 - $26.90
52 week range
$7.67 - $27.03
Volume
280,937
Avg. Volume (30 days)
987,283
Market Cap
$2.61B
Dividend Yield
0.00%
P/E
-
Shares Outstanding
97,235,316
Open
$26.89
Previous Close
$26.89
Days Range
$26.87 - $26.90
52 week range
$7.67 - $27.03
Volume
280,937
Avg. Volume (30 days)
987,283
Market Cap
$2.61B
Dividend Yield
0.00%
P/E
-
Shares Outstanding
97,235,316

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR MYOVANT SCIENCES LTD
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Lang MatthewGeneral Counsel & Corp. Secy.Jan 18, 2023 Sale$26.891,27234,204354,303Jan 20, 2023, 04:36 PM
Merendino LaurenChief Commercial OfficerJan 18, 2023 Sale$26.892,00853,995169,538Jan 20, 2023, 04:34 PM
Marek David CPrincipal Executive OfficerJan 18, 2023 Sale$26.898,037216,115417,599Jan 20, 2023, 04:34 PM
Arjona Ferreira Juan CamiloChief Medical OfficerJan 18, 2023 Sale$26.891,10929,821246,684Jan 20, 2023, 04:31 PM
Arjona Ferreira Juan CamiloChief Medical OfficerJan 04, 2023 Sale$26.902,25160,552247,793Jan 05, 2023, 05:21 PM
Lang MatthewGeneral Counsel & Corp. Secy.Jan 04, 2023 Sale$26.902,77974,755355,575Jan 05, 2023, 05:20 PM
Mehra UneekPrincipal Financial OfficerDec 16, 2022 Sale$26.752,24159,947202,696Dec 20, 2022, 08:07 PM
Merendino LaurenChief Commercial OfficerOct 18, 2022 Sale$25.201,70342,916171,546Oct 20, 2022, 04:54 PM
Marek David CPrincipal Executive OfficerOct 18, 2022 Sale$25.2011,156281,131425,636Oct 20, 2022, 04:53 PM
Lang MatthewGeneral Counsel & Corp. Secy.Oct 18, 2022 Sale$25.201,93348,712358,354Oct 20, 2022, 04:51 PM
Arjona Ferreira Juan CamiloChief Medical OfficerOct 18, 2022 Sale$25.201,60440,421250,044Oct 20, 2022, 04:50 PM
Arjona Ferreira Juan CamiloChief Medical OfficerOct 04, 2022 Sale$24.402,73866,807251,648Oct 06, 2022, 04:28 PM
Lang MatthewGeneral Counsel & Corp. Secy.Oct 04, 2022 Sale$24.403,67989,768360,287Oct 06, 2022, 04:26 PM
Mehra UneekPrincipal Financial OfficerSep 16, 2022 Sale$18.869,243174,323204,937Sep 20, 2022, 04:56 PM
Lang MatthewGeneral Counsel & Corp. Secy.Aug 15, 2022 Sale$18.2331,214569,031363,966Aug 16, 2022, 05:01 PM
Lang MatthewGeneral Counsel & Corp. Secy.Jul 18, 2022 Sale$12.871,93524,903270,400Jul 20, 2022, 04:38 PM
Merendino LaurenChief Commercial OfficerJul 18, 2022 Sale$12.871,70421,930173,249Jul 20, 2022, 04:37 PM
Marek David CPrincipal Executive OfficerJul 18, 2022 Sale$12.8711,164143,681436,792Jul 20, 2022, 04:36 PM
Arjona Ferreira Juan CamiloChief Medical OfficerJul 18, 2022 Sale$12.871,60620,669254,386Jul 20, 2022, 04:35 PM
Arjona Ferreira Juan CamiloChief Medical OfficerJul 06, 2022 Sale$13.402,75536,917255,992Jul 08, 2022, 04:09 PM
Lang MatthewGeneral Counsel & Corp. Secy.Jul 06, 2022 Sale$13.403,70249,607272,335Jul 08, 2022, 04:08 PM
Arjona Ferreira Juan CamiloChief Medical OfficerMay 27, 2022 Sale$10.071,38213,917258,747Jun 01, 2022, 04:20 PM
Lang MatthewGeneral Counsel & Corp. Secy.Apr 19, 2022 Sale$10.458,00283,621276,037Apr 21, 2022, 04:28 PM
Arjona Ferreira Juan CamiloChief Medical OfficerApr 19, 2022 Sale$10.454,63248,404260,129Apr 21, 2022, 04:27 PM
Merendino LaurenChief Commercial OfficerApr 19, 2022 Sale$10.457,04973,662174,953Apr 21, 2022, 04:25 PM
Marek David CPrincipal Executive OfficerApr 19, 2022 Sale$10.4524,594257,007447,956Apr 21, 2022, 04:25 PM
Lang MatthewGeneral Counsel & Corp. Secy.Apr 05, 2022 Sale$13.782,43633,568172,928Apr 07, 2022, 04:19 PM
Arjona Ferreira Juan CamiloChief Medical OfficerApr 05, 2022 Sale$13.781,92226,485161,058Apr 07, 2022, 04:16 PM
Marek David CPrincipal Executive OfficerJan 19, 2022 Sale$14.6819,882291,868337,983Jan 21, 2022, 04:08 PM
Lang MatthewGeneral Counsel & Corp. Secy.Jan 04, 2022 Sale$16.274,47572,808175,364Jan 06, 2022, 04:46 PM
Arjona Ferreira Juan CamiloChief Medical OfficerJan 04, 2022 Sale$16.272,27136,949164,342Jan 06, 2022, 04:21 PM
Arjona Ferreira Juan CamiloChief Medical OfficerNov 29, 2021 Sale$19.301,97838,175166,613Dec 01, 2021, 04:10 PM
Arjona Ferreira Juan CamiloChief Medical OfficerNov 03, 2021 Option Exercise$7.787005,446169,291Nov 05, 2021, 04:27 PM
Arjona Ferreira Juan CamiloChief Medical OfficerNov 04, 2021 Option Exercise$7.783,10024,118171,691Nov 05, 2021, 04:27 PM
Arjona Ferreira Juan CamiloChief Medical OfficerNov 04, 2021 Sale$24.023,10074,462168,591Nov 05, 2021, 04:27 PM
Arjona Ferreira Juan CamiloChief Medical OfficerNov 03, 2021 Sale$24.0070016,800168,591Nov 05, 2021, 04:27 PM
Arjona Ferreira Juan CamiloChief Medical OfficerOct 05, 2021 Sale$21.622,73859,196168,591Oct 07, 2021, 04:03 PM
Lang MatthewGeneral Counsel & Corp. Secy.Oct 05, 2021 Sale$21.626,671144,227179,839Oct 07, 2021, 04:02 PM
Sumitomo Chemical Co., Ltd.10% OwnerSep 28, 2021 Buy$22.8520,677472,38350,041,181Sep 30, 2021, 05:00 PM
Arjona Ferreira Juan CamiloChief Medical OfficerSep 27, 2021 Option Exercise$7.787,00054,460178,329Sep 29, 2021, 04:12 PM
Arjona Ferreira Juan CamiloChief Medical OfficerSep 27, 2021 Sale$24.327,000170,240171,329Sep 29, 2021, 04:12 PM
Sumitomo Chemical Co., Ltd.10% OwnerSep 27, 2021 Buy$24.2248,0001,162,39050,020,504Sep 28, 2021, 05:00 PM
Sumitomo Chemical Co., Ltd.10% OwnerSep 24, 2021 Buy$23.4036,000842,54849,972,504Sep 28, 2021, 05:00 PM
Sumitomo Chemical Co., Ltd.10% OwnerSep 22, 2021 Buy$21.9684,0181,845,01049,881,726Sep 24, 2021, 05:00 PM
Sumitomo Chemical Co., Ltd.10% OwnerSep 23, 2021 Buy$23.0654,7781,263,21649,936,504Sep 24, 2021, 05:00 PM
Sumitomo Chemical Co., Ltd.10% OwnerSep 21, 2021 Buy$22.4843,000966,45149,797,708Sep 22, 2021, 05:00 PM
Sumitomo Chemical Co., Ltd.10% OwnerSep 20, 2021 Buy$22.1038,273845,66949,754,708Sep 22, 2021, 05:00 PM
Sumitomo Chemical Co., Ltd.10% OwnerSep 17, 2021 Buy$22.7937,913864,10549,716,435Sep 20, 2021, 05:00 PM
Sumitomo Chemical Co., Ltd.10% OwnerSep 16, 2021 Buy$21.7550,0001,087,55049,678,522Sep 20, 2021, 05:00 PM
Sumitomo Chemical Co., Ltd.10% OwnerSep 14, 2021 Buy$22.1071,3001,575,68649,538,658Sep 16, 2021, 05:00 PM
Sumitomo Chemical Co., Ltd.10% OwnerSep 15, 2021 Buy$21.9889,8641,975,48949,628,522Sep 16, 2021, 05:00 PM
Sumitomo Chemical Co., Ltd.10% OwnerSep 13, 2021 Buy$23.3883,1781,945,04949,467,358Sep 14, 2021, 05:00 PM
Sumitomo Chemical Co., Ltd.10% OwnerSep 10, 2021 Buy$25.1130,000753,39049,384,180Sep 14, 2021, 05:00 PM
Curran TerrieDirectorSep 09, 2021 Option Exercise$7.654,85037,1034,850Sep 13, 2021, 04:11 PM
Curran TerrieDirectorSep 09, 2021 Sale$25.584,850124,0630Sep 13, 2021, 04:11 PM
Sumitomo Chemical Co., Ltd.10% OwnerSep 09, 2021 Buy$25.5237,000944,14749,354,180Sep 10, 2021, 05:00 PM
Sumitomo Chemical Co., Ltd.10% OwnerSep 08, 2021 Buy$25.7421,902563,66349,317,180Sep 10, 2021, 05:00 PM
Sumitomo Chemical Co., Ltd.10% OwnerSep 07, 2021 Buy$26.2333,200870,92949,295,278Sep 08, 2021, 05:00 PM
Sumitomo Chemical Co., Ltd.10% OwnerSep 03, 2021 Buy$26.7631,200834,99449,262,078Sep 08, 2021, 05:00 PM
Sumitomo Chemical Co., Ltd.10% OwnerSep 02, 2021 Buy$26.0863,1021,645,89349,230,878Sep 03, 2021, 05:00 PM
Sumitomo Chemical Co., Ltd.10% OwnerSep 01, 2021 Buy$24.8340,000993,02849,167,776Sep 03, 2021, 05:00 PM
Curran TerrieDirectorSep 01, 2021 Option Exercise$7.6511,37387,00311,373Sep 03, 2021, 04:25 PM
Curran TerrieDirectorSep 02, 2021 Option Exercise$7.6537,135284,08337,135Sep 03, 2021, 04:25 PM
Curran TerrieDirectorSep 01, 2021 Sale$25.0011,373284,3250Sep 03, 2021, 04:25 PM
Curran TerrieDirectorSep 02, 2021 Sale$25.0337,135929,4890Sep 03, 2021, 04:25 PM
Sumitomo Chemical Co., Ltd.10% OwnerAug 31, 2021 Buy$24.2839,000946,88549,127,776Sep 01, 2021, 05:00 PM
Sumitomo Chemical Co., Ltd.10% OwnerAug 30, 2021 Buy$23.9270,0001,674,09949,088,776Sep 01, 2021, 05:00 PM
Arjona Ferreira Juan CamiloChief Medical OfficerAug 30, 2021 Option Exercise$7.7821,000163,380192,329Aug 31, 2021, 05:23 PM
Arjona Ferreira Juan CamiloChief Medical OfficerAug 27, 2021 Sale$22.691,97844,881171,329Aug 31, 2021, 05:23 PM
Arjona Ferreira Juan CamiloChief Medical OfficerAug 30, 2021 Sale$24.0521,000505,050171,329Aug 31, 2021, 05:23 PM
Sumitomo Chemical Co., Ltd.10% OwnerAug 27, 2021 Buy$23.1737,038858,25249,018,776Aug 30, 2021, 05:00 PM
Sumitomo Chemical Co., Ltd.10% OwnerAug 26, 2021 Buy$22.6740,000906,91248,981,738Aug 30, 2021, 05:00 PM
Sumitomo Chemical Co., Ltd.10% OwnerAug 25, 2021 Buy$22.4428,709644,15848,941,738Aug 26, 2021, 05:00 PM
Sumitomo Chemical Co., Ltd.10% OwnerAug 24, 2021 Buy$22.3734,299767,26948,913,029Aug 26, 2021, 05:00 PM
Sumitomo Chemical Co., Ltd.10% OwnerAug 23, 2021 Buy$22.3055,4471,236,73648,878,730Aug 24, 2021, 05:00 PM
Sumitomo Chemical Co., Ltd.10% OwnerAug 20, 2021 Buy$20.8646,478969,54048,823,283Aug 24, 2021, 05:00 PM
Sumitomo Chemical Co., Ltd.10% OwnerAug 19, 2021 Buy$21.5146,7921,006,42148,776,805Aug 20, 2021, 05:00 PM
Sumitomo Chemical Co., Ltd.10% OwnerAug 18, 2021 Buy$21.4517,116367,09248,730,013Aug 20, 2021, 05:00 PM
Sumitomo Chemical Co., Ltd.10% OwnerAug 17, 2021 Buy$20.8923,549492,04948,712,897Aug 18, 2021, 05:05 PM
Sumitomo Chemical Co., Ltd.10% OwnerAug 16, 2021 Buy$21.3748,1671,029,14548,689,348Aug 18, 2021, 05:05 PM
Lang MatthewGeneral Counsel & Corp. Secy.Jul 09, 2021 Sale$21.526,954149,650186,510Jul 13, 2021, 04:21 PM
Arjona Ferreira Juan CamiloChief Medical OfficerJul 07, 2021 Sale$21.752,77760,400173,307Jul 09, 2021, 04:30 PM
KARBE FRANKPrincipal Fin'l & AccountingJul 07, 2021 Sale$21.753,23270,296212,296Jul 09, 2021, 04:27 PM
Lang MatthewGeneral Counsel & Corp. Secy.Apr 06, 2021 Sale$18.6210,862202,250135,003Apr 08, 2021, 04:57 PM
KARBE FRANKPrincipal Fin'l & AccountingApr 06, 2021 Sale$18.6311,080206,420152,390Apr 08, 2021, 04:55 PM
Arjona Ferreira Juan CamiloChief Medical OfficerMar 19, 2021 Option Exercise$7.787,00054,460141,535Mar 23, 2021, 04:23 PM
Arjona Ferreira Juan CamiloChief Medical OfficerMar 19, 2021 Sale$24.177,000169,190134,535Mar 23, 2021, 04:23 PM
Lang MatthewGeneral Counsel & Corp. Secy.Mar 15, 2021 Option Exercise$7.7830,000233,400175,865Mar 17, 2021, 04:06 PM
Lang MatthewGeneral Counsel & Corp. Secy.Mar 15, 2021 Sale$25.0730,000752,013145,865Mar 17, 2021, 04:06 PM
Arjona Ferreira Juan CamiloChief Medical OfficerMar 01, 2021 Sale$22.551,51334,118134,535Mar 03, 2021, 04:52 PM
KARBE FRANKPrincipal Fin'l & AccountingFeb 16, 2021 Option Exercise$5.117503,833164,220Feb 18, 2021, 04:52 PM
KARBE FRANKPrincipal Fin'l & AccountingFeb 16, 2021 Sale$21.4075016,050163,470Feb 18, 2021, 04:52 PM
KARBE FRANKPrincipal Fin'l & AccountingJan 28, 2021 Option Exercise$5.113001,533163,770Feb 01, 2021, 04:29 PM
KARBE FRANKPrincipal Fin'l & AccountingJan 28, 2021 Sale$24.003007,200163,470Feb 01, 2021, 04:29 PM
KARBE FRANKPrincipal Fin'l & AccountingJan 15, 2021 Option Exercise$5.117503,833164,220Jan 20, 2021, 04:39 PM
KARBE FRANKPrincipal Fin'l & AccountingJan 15, 2021 Sale$21.5075016,125163,470Jan 20, 2021, 04:39 PM
KARBE FRANKPrincipal Fin'l & AccountingDec 28, 2020 Option Exercise$5.1111,80060,298175,270Dec 30, 2020, 04:29 PM
KARBE FRANKPrincipal Fin'l & AccountingDec 28, 2020 Sale$30.0011,800354,000163,470Dec 30, 2020, 04:29 PM
Arjona Ferreira Juan CamiloChief Medical OfficerDec 18, 2020 Option Exercise$7.782,00015,560138,048Dec 22, 2020, 04:34 PM
Arjona Ferreira Juan CamiloChief Medical OfficerDec 18, 2020 Sale$26.002,00052,000136,048Dec 22, 2020, 04:34 PM
Lang MatthewGeneral Counsel & Corp. Secy.Dec 18, 2020 Option Exercise$7.7810,00077,800155,865Dec 22, 2020, 04:33 PM
Lang MatthewGeneral Counsel & Corp. Secy.Dec 18, 2020 Sale$25.4110,000254,054146,165Dec 22, 2020, 04:33 PM
Arjona Ferreira Juan CamiloChief Medical OfficerDec 15, 2020 Option Exercise$7.787,00054,460143,048Dec 17, 2020, 04:54 PM
Arjona Ferreira Juan CamiloChief Medical OfficerDec 15, 2020 Sale$23.927,000167,426139,515Dec 17, 2020, 04:54 PM
KARBE FRANKPrincipal Fin'l & AccountingDec 15, 2020 Option Exercise$5.111,0505,366164,520Dec 17, 2020, 04:51 PM
KARBE FRANKPrincipal Fin'l & AccountingDec 15, 2020 Sale$24.151,05025,363164,140Dec 17, 2020, 04:51 PM
Arjona Ferreira Juan CamiloChief Medical OfficerDec 10, 2020 Option Exercise$7.7810,00077,800146,048Dec 14, 2020, 04:21 PM
Arjona Ferreira Juan CamiloChief Medical OfficerDec 10, 2020 Sale$26.0410,000260,362136,048Dec 14, 2020, 04:21 PM
Lang MatthewGeneral Counsel & Corp. Secy.Dec 10, 2020 Option Exercise$7.7819,400150,932165,265Dec 11, 2020, 04:22 PM
Lang MatthewGeneral Counsel & Corp. Secy.Dec 09, 2020 Option Exercise$7.786004,668146,465Dec 11, 2020, 04:22 PM
Lang MatthewGeneral Counsel & Corp. Secy.Dec 09, 2020 Sale$25.0860015,049145,865Dec 11, 2020, 04:22 PM
Lang MatthewGeneral Counsel & Corp. Secy.Dec 10, 2020 Sale$25.1919,400488,783145,865Dec 11, 2020, 04:22 PM
Arjona Ferreira Juan CamiloChief Medical OfficerNov 30, 2020 Sale$23.651,97846,780136,048Dec 02, 2020, 05:10 PM
KARBE FRANKPrincipal Fin'l & AccountingNov 30, 2020 Option Exercise$5.111,5007,665164,970Dec 02, 2020, 05:08 PM
KARBE FRANKPrincipal Fin'l & AccountingNov 30, 2020 Sale$24.001,50036,000163,470Dec 02, 2020, 05:08 PM
KARBE FRANKPrincipal Fin'l & AccountingNov 17, 2020 Option Exercise$5.117503,833164,220Nov 19, 2020, 05:04 PM
KARBE FRANKPrincipal Fin'l & AccountingNov 17, 2020 Sale$20.0075015,000163,470Nov 19, 2020, 05:04 PM
Arjona Ferreira Juan CamiloChief Medical OfficerNov 17, 2020 Option Exercise$7.787,00054,460145,026Nov 19, 2020, 05:00 PM
Arjona Ferreira Juan CamiloChief Medical OfficerNov 17, 2020 Sale$20.007,000140,000138,026Nov 19, 2020, 05:00 PM
KARBE FRANKPrincipal Fin'l & AccountingNov 13, 2020 Option Exercise$5.117503,833164,220Nov 17, 2020, 06:50 PM
KARBE FRANKPrincipal Fin'l & AccountingNov 13, 2020 Sale$20.0075015,000163,470Nov 17, 2020, 06:50 PM
Arjona Ferreira Juan CamiloChief Medical OfficerNov 13, 2020 Option Exercise$7.787,00054,460145,026Nov 17, 2020, 06:49 PM
Arjona Ferreira Juan CamiloChief Medical OfficerNov 13, 2020 Sale$20.007,000140,000138,026Nov 17, 2020, 06:49 PM
KARBE FRANKPrincipal Fin'l & AccountingSep 15, 2020 Option Exercise$5.117503,833164,220Sep 17, 2020, 04:20 PM
KARBE FRANKPrincipal Fin'l & AccountingSep 15, 2020 Sale$21.7375016,297163,470Sep 17, 2020, 04:20 PM
Arjona Ferreira Juan CamiloChief Medical OfficerSep 15, 2020 Option Exercise$7.787,00054,460145,026Sep 17, 2020, 04:18 PM
Arjona Ferreira Juan CamiloChief Medical OfficerSep 15, 2020 Sale$21.777,000152,389138,126Sep 17, 2020, 04:18 PM
Lang MatthewGeneral Counsel & Corp. Secy.Aug 31, 2020 Option Exercise$7.7826,700207,726172,565Sep 02, 2020, 04:47 PM
Lang MatthewGeneral Counsel & Corp. Secy.Aug 31, 2020 Sale$20.0526,700535,282145,865Sep 02, 2020, 04:47 PM
Arjona Ferreira Juan CamiloChief Medical OfficerAug 31, 2020 Option Exercise$7.7811,30787,968149,333Sep 02, 2020, 04:42 PM
Arjona Ferreira Juan CamiloChief Medical OfficerAug 31, 2020 Sale$20.0011,307226,197138,026Sep 02, 2020, 04:42 PM
KARBE FRANKPrincipal Fin'l & AccountingAug 28, 2020 Option Exercise$5.113,65018,652167,120Sep 01, 2020, 04:37 PM
KARBE FRANKPrincipal Fin'l & AccountingAug 31, 2020 Option Exercise$5.1121,150108,077184,620Sep 01, 2020, 04:37 PM
KARBE FRANKPrincipal Fin'l & AccountingAug 31, 2020 Sale$20.0121,150423,275163,470Sep 01, 2020, 04:37 PM
KARBE FRANKPrincipal Fin'l & AccountingAug 28, 2020 Sale$20.043,65073,146163,470Sep 01, 2020, 04:37 PM
Arjona Ferreira Juan CamiloChief Medical OfficerAug 28, 2020 Option Exercise$7.782,05816,011140,084Aug 31, 2020, 05:02 PM
Arjona Ferreira Juan CamiloChief Medical OfficerAug 28, 2020 Sale$20.012,05841,181138,026Aug 31, 2020, 05:02 PM
Arjona Ferreira Juan CamiloChief Medical OfficerAug 27, 2020 Sale$18.807,089133,273138,026Aug 31, 2020, 05:02 PM
Lang MatthewGeneral Counsel & Corp. Secy.Aug 26, 2020 Option Exercise$7.78100778145,965Aug 28, 2020, 05:41 PM
Lang MatthewGeneral Counsel & Corp. Secy.Aug 28, 2020 Option Exercise$7.782,60020,228148,465Aug 28, 2020, 05:41 PM
Lang MatthewGeneral Counsel & Corp. Secy.Aug 28, 2020 Sale$20.022,60052,052145,865Aug 28, 2020, 05:41 PM
Lang MatthewGeneral Counsel & Corp. Secy.Aug 26, 2020 Sale$20.001002,000145,865Aug 28, 2020, 05:41 PM
KARBE FRANKPrincipal Fin'l & AccountingAug 19, 2020 Option Exercise$5.117003,577164,170Aug 21, 2020, 05:07 PM
KARBE FRANKPrincipal Fin'l & AccountingAug 19, 2020 Sale$20.0070014,000163,470Aug 21, 2020, 05:07 PM
Lang MatthewGeneral Counsel & Corp. Secy.Aug 19, 2020 Option Exercise$7.786004,668146,465Aug 21, 2020, 05:04 PM
Lang MatthewGeneral Counsel & Corp. Secy.Aug 19, 2020 Sale$20.0060012,000145,865Aug 21, 2020, 05:04 PM
Arjona Ferreira Juan CamiloChief Medical OfficerAug 19, 2020 Option Exercise$7.786354,940145,750Aug 21, 2020, 05:02 PM
Arjona Ferreira Juan CamiloChief Medical OfficerAug 19, 2020 Sale$20.0063512,700145,115Aug 21, 2020, 05:02 PM
Arjona Ferreira Juan CamiloChief Medical OfficerJun 24, 2020 Option Exercise$7.7817,446135,730162,561Jun 26, 2020, 04:23 PM
Arjona Ferreira Juan CamiloChief Medical OfficerJun 24, 2020 Sale$20.0017,446348,920145,115Jun 26, 2020, 04:23 PM
Arjona Ferreira Juan CamiloChief Medical OfficerJun 23, 2020 Option Exercise$7.784,05431,540149,169Jun 24, 2020, 04:16 PM
Arjona Ferreira Juan CamiloChief Medical OfficerJun 23, 2020 Sale$20.004,05481,080145,115Jun 24, 2020, 04:16 PM
Sumitomo Chemical Co., Ltd.10% OwnerMay 19, 2020 Buy$12.1050,000605,05048,603,284May 21, 2020, 01:25 PM
Sumitomo Chemical Co., Ltd.10% OwnerMay 20, 2020 Buy$12.5837,897476,86248,641,181May 21, 2020, 01:25 PM
Sumitomo Chemical Co., Ltd.10% OwnerMay 18, 2020 Buy$12.3635,000432,62448,553,284May 19, 2020, 03:13 PM
Sumitomo Chemical Co., Ltd.10% OwnerMay 15, 2020 Buy$12.1249,812603,96648,518,284May 19, 2020, 03:13 PM
Sumitomo Chemical Co., Ltd.10% OwnerMay 14, 2020 Buy$12.0250,000600,76048,468,472May 15, 2020, 03:28 PM
Sumitomo Chemical Co., Ltd.10% OwnerMay 13, 2020 Buy$12.3841,331511,64148,418,472May 15, 2020, 03:28 PM
Sumitomo Chemical Co., Ltd.10% OwnerMay 12, 2020 Buy$13.5124,448330,40548,377,141May 13, 2020, 06:50 PM
Sumitomo Chemical Co., Ltd.10% OwnerMay 11, 2020 Buy$12.7835,000447,38448,352,693May 13, 2020, 06:50 PM
Sumitomo Chemical Co., Ltd.10% OwnerMay 06, 2020 Buy$12.2450,000612,07548,247,693May 11, 2020, 04:07 PM
Sumitomo Chemical Co., Ltd.10% OwnerMay 08, 2020 Buy$12.8335,000449,07448,317,693May 11, 2020, 04:01 PM
Sumitomo Chemical Co., Ltd.10% OwnerMay 07, 2020 Buy$12.6335,000442,13748,282,693May 11, 2020, 04:01 PM
Sumitomo Chemical Co., Ltd.10% OwnerMay 05, 2020 Buy$11.97100,0001,196,54048,247,693May 07, 2020, 09:26 AM
Sumitomo Chemical Co., Ltd.10% OwnerMay 04, 2020 Buy$11.5050,000574,87048,147,693May 05, 2020, 03:40 PM
Sumitomo Chemical Co., Ltd.10% OwnerMay 01, 2020 Buy$11.3850,000569,18048,097,693May 05, 2020, 03:40 PM
Sumitomo Chemical Co., Ltd.10% OwnerApr 30, 2020 Buy$12.0850,000603,82548,047,693May 01, 2020, 05:35 PM
Sumitomo Chemical Co., Ltd.10% OwnerApr 29, 2020 Buy$11.9250,000595,89547,997,693May 01, 2020, 05:35 PM
Sumitomo Chemical Co., Ltd.10% OwnerApr 28, 2020 Buy$12.0550,000602,72047,947,693Apr 29, 2020, 01:38 PM
Sumitomo Chemical Co., Ltd.10% OwnerApr 27, 2020 Buy$12.1840,503493,30247,897,693Apr 29, 2020, 01:38 PM
Sumitomo Chemical Co., Ltd.10% OwnerApr 24, 2020 Buy$12.1543,086523,34447,857,190Apr 27, 2020, 11:30 AM
Sumitomo Chemical Co., Ltd.10% OwnerApr 23, 2020 Buy$12.3535,000432,10347,814,104Apr 27, 2020, 11:30 AM
Sumitomo Chemical Co., Ltd.10% OwnerApr 21, 2020 Buy$11.5850,200581,14047,729,104Apr 23, 2020, 02:21 PM
Sumitomo Chemical Co., Ltd.10% OwnerApr 22, 2020 Buy$11.9350,000596,73047,779,104Apr 23, 2020, 02:21 PM
Sumitomo Chemical Co., Ltd.10% OwnerApr 20, 2020 Buy$11.8250,300594,42547,678,904Apr 21, 2020, 04:01 PM
Sumitomo Chemical Co., Ltd.10% OwnerApr 17, 2020 Buy$10.7670,000753,53647,628,604Apr 21, 2020, 04:01 PM
Sumitomo Chemical Co., Ltd.10% OwnerApr 16, 2020 Buy$10.6470,000744,67447,558,604Apr 17, 2020, 12:38 PM
Sumitomo Chemical Co., Ltd.10% OwnerApr 15, 2020 Buy$10.4870,000733,69847,488,604Apr 17, 2020, 12:38 PM
Sumitomo Chemical Co., Ltd.10% OwnerApr 14, 2020 Buy$11.0070,000770,10547,418,604Apr 15, 2020, 07:22 PM
Sumitomo Chemical Co., Ltd.10% OwnerApr 13, 2020 Buy$9.8170,000686,54647,348,604Apr 15, 2020, 07:22 PM
Sumitomo Chemical Co., Ltd.10% OwnerApr 09, 2020 Buy$9.3770,000655,66947,278,604Apr 13, 2020, 02:25 PM
Sumitomo Chemical Co., Ltd.10% OwnerApr 08, 2020 Buy$8.5370,000596,93947,208,604Apr 09, 2020, 11:20 AM
Sumitomo Chemical Co., Ltd.10% OwnerApr 07, 2020 Buy$8.2170,000574,36447,138,604Apr 09, 2020, 11:20 AM
Sumitomo Chemical Co., Ltd.10% OwnerApr 06, 2020 Buy$8.4470,000590,52047,068,604Apr 07, 2020, 01:56 PM
Sumitomo Chemical Co., Ltd.10% OwnerApr 03, 2020 Buy$7.9370,000554,92546,998,604Apr 07, 2020, 01:56 PM
Sumitomo Chemical Co., Ltd.10% OwnerApr 01, 2020 Buy$7.4670,000522,29846,858,604Apr 03, 2020, 03:04 PM
Sumitomo Chemical Co., Ltd.10% OwnerApr 02, 2020 Buy$7.7370,000541,08646,928,604Apr 03, 2020, 03:04 PM
Sumitomo Chemical Co., Ltd.10% OwnerMar 31, 2020 Buy$7.9770,000557,98446,788,604Apr 01, 2020, 10:55 AM
Sumitomo Chemical Co., Ltd.10% OwnerMar 30, 2020 Buy$7.6570,000535,76646,718,604Apr 01, 2020, 10:55 AM
Sumitomo Chemical Co., Ltd.10% OwnerMar 27, 2020 Buy$7.9770,000558,25046,648,604Mar 30, 2020, 11:34 AM
Sumitomo Chemical Co., Ltd.10% OwnerMar 26, 2020 Buy$7.9470,000555,80746,578,604Mar 30, 2020, 11:34 AM
Sumitomo Chemical Co., Ltd.10% OwnerMar 25, 2020 Buy$7.60108,100821,89546,508,604Mar 26, 2020, 11:39 AM
Sumitomo Chemical Co., Ltd.10% OwnerMar 24, 2020 Buy$7.67211,2001,620,55946,400,504Mar 26, 2020, 11:39 AM
Sumitomo Chemical Co., Ltd.10% OwnerMar 23, 2020 Buy$7.68211,2001,621,93146,189,304Mar 24, 2020, 03:15 PM
Sumitomo Chemical Co., Ltd.10% OwnerMar 20, 2020 Buy$7.60193,9001,472,70945,978,104Mar 24, 2020, 03:15 PM
Sumitomo Chemical Co., Ltd.10% OwnerMar 19, 2020 Buy$7.68193,9001,488,95845,784,204Mar 20, 2020, 02:10 PM
Sumitomo Chemical Co., Ltd.10% OwnerMar 18, 2020 Buy$7.40193,9001,434,93845,590,304Mar 20, 2020, 02:10 PM
Sablich KimChief Commercial OfficerMar 18, 2020 Sale$7.377855,78758,920Mar 19, 2020, 04:32 PM
Sumitomo Chemical Co., Ltd.10% OwnerMar 16, 2020 Buy$7.25193,9001,406,00845,202,504Mar 18, 2020, 04:21 PM
Sumitomo Chemical Co., Ltd.10% OwnerMar 17, 2020 Buy$7.40193,9001,433,94945,396,404Mar 18, 2020, 04:21 PM
Sablich KimChief Commercial OfficerJan 15, 2020 Sale$14.044,84067,95459,690Jan 16, 2020, 05:28 PM
Lang MatthewGeneral Counsel & Corp. Secy.Dec 30, 2019 Sale$15.5519,018295,73034,597Dec 30, 2019, 07:14 PM
KARBE FRANKPrincipal Fin'l & AccountingDec 30, 2019 Sale$15.5519,701306,35143,324Dec 30, 2019, 07:13 PM
Sablich KimChief Commercial OfficerDec 18, 2019 Sale$16.222,58541,92964,530Dec 19, 2019, 04:25 PM
Roivant Sciences Ltd.10% OwnerDec 16, 2019 Buy$15.13170,0002,572,20644,933,604Dec 18, 2019, 04:28 PM
Roivant Sciences Ltd.10% OwnerDec 17, 2019 Buy$15.9475,0001,195,50045,008,604Dec 18, 2019, 04:28 PM
Roivant Sciences Ltd.10% OwnerDec 04, 2019 Buy$17.0675,0001,279,31544,763,604Dec 04, 2019, 06:08 PM
Roivant Sciences Ltd.10% OwnerDec 02, 2019 Buy$18.44179,1933,305,04044,688,604Dec 04, 2019, 06:08 PM
Roivant Sciences Ltd.10% OwnerNov 25, 2019 Buy$15.003,500,00052,500,00044,509,411Nov 27, 2019, 04:45 PM
Roivant Sciences Ltd.10% OwnerNov 21, 2019 Buy$11.89121,9061,449,10141,009,411Nov 22, 2019, 09:28 PM
Roivant Sciences Ltd.10% OwnerNov 20, 2019 Buy$12.90121,9061,572,58740,887,505Nov 22, 2019, 09:28 PM
Sebelius KathleenDirectorJun 12, 2019 Buy$8.965,00044,7845,000Jun 14, 2019, 04:20 PM
VIKING GLOBAL INVESTORS LP10% OwnerJun 04, 2019 Buy$8.252,424,24219,999,99740,765,599Jun 13, 2019, 03:47 PM
VIKING GLOBAL PERFORMANCE LLC10% OwnerJun 04, 2019 Buy$8.252,424,24219,999,99740,765,599Jun 13, 2019, 03:45 PM
KARBE FRANKPrincipal Fin'l & AccountingJun 11, 2019 Buy$9.108,00072,8008,000Jun 11, 2019, 04:55 PM
QVT Associates GP LLC10% OwnerJun 04, 2019 Buy$8.252,424,24219,999,99740,765,599Jun 06, 2019, 08:05 PM
SVF Investments (UK) Ltd10% OwnerJun 04, 2019 Buy$8.252,424,24219,999,99740,765,599Jun 06, 2019, 06:30 PM
Machado Patrick10% OwnerJun 04, 2019 Buy$8.252,424,24219,999,99740,765,599Jun 06, 2019, 06:30 PM
Dexxon Holdings Ltd.10% OwnerJun 04, 2019 Buy$8.252,424,24219,999,99740,765,599Jun 06, 2019, 06:29 PM
Lo Andrew10% OwnerJun 04, 2019 Buy$8.252,424,24219,999,99740,765,599Jun 06, 2019, 06:07 PM
Roivant Sciences Ltd.10% OwnerJun 04, 2019 Buy$8.252,424,24219,999,99740,765,599Jun 06, 2019, 06:00 PM
Arjona Ferreira Juan CamiloChief Medical OfficerFeb 15, 2019 Sale$21.152605,4999,740Feb 20, 2019, 04:25 PM
Altmeyer MarkDirectorNov 17, 2017 Buy$13.383,50046,8303,500Jun 15, 2018, 05:20 PM
VIKING GLOBAL INVESTORS LP10% OwnerApr 02, 2018 Buy$20.271,110,01522,500,00538,341,357Apr 05, 2018, 06:02 AM
VIKING GLOBAL PERFORMANCE LLC10% OwnerApr 02, 2018 Buy$20.271,110,01522,500,00538,341,357Apr 04, 2018, 09:58 PM
Dexxon Holdings Ltd.10% OwnerApr 02, 2018 Buy$20.271,110,01522,500,00538,341,357Apr 04, 2018, 07:18 PM
Lo Andrew10% OwnerApr 02, 2018 Buy$20.271,110,01522,500,00538,341,357Apr 04, 2018, 05:00 PM
SVF Investments (UK) Ltd10% OwnerApr 02, 2018 Buy$20.271,110,01522,500,00538,341,357Apr 04, 2018, 04:59 PM
Roivant Sciences Ltd.10% OwnerApr 02, 2018 Buy$20.271,110,01522,500,00538,341,357Apr 04, 2018, 04:52 PM
Machado Patrick10% OwnerApr 02, 2018 Buy$20.271,110,01522,500,00538,341,357Apr 04, 2018, 04:51 PM
QVT Associates GP LLCDirectorApr 02, 2018 Buy$20.271,110,01522,500,00538,341,357Apr 04, 2018, 04:29 PM
Takeda Pharmaceuticals International AG10% OwnerMar 19, 2018 Buy$18.677,420,625138,543,0697,420,625Mar 21, 2018, 09:42 PM
Takeda Pharmaceuticals International AG10% OwnerMar 19, 2018 Sale$18.677,420,625138,543,0690Mar 21, 2018, 09:42 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Lang MatthewGeneral Counsel & Corp. Secy.01/18/202334,204
Merendino LaurenChief Commercial Officer01/18/202353,995
Marek David CPrincipal Executive Officer01/18/2023216,115
Arjona Ferreira Juan CamiloChief Medical Officer01/18/202329,821
Arjona Ferreira Juan CamiloChief Medical Officer01/04/202360,552
Lang MatthewGeneral Counsel & Corp. Secy.01/04/202374,755
Mehra UneekPrincipal Financial Officer12/16/202259,947
Merendino LaurenChief Commercial Officer10/18/202242,916
Marek David CPrincipal Executive Officer10/18/2022281,131
Lang MatthewGeneral Counsel & Corp. Secy.10/18/202248,712
Arjona Ferreira Juan CamiloChief Medical Officer10/18/202240,421
Arjona Ferreira Juan CamiloChief Medical Officer10/04/202266,807
Lang MatthewGeneral Counsel & Corp. Secy.10/04/202289,768
Mehra UneekPrincipal Financial Officer09/16/2022174,323
Lang MatthewGeneral Counsel & Corp. Secy.08/15/2022569,031
Lang MatthewGeneral Counsel & Corp. Secy.07/18/202224,903
Merendino LaurenChief Commercial Officer07/18/202221,930
Marek David CPrincipal Executive Officer07/18/2022143,681
Arjona Ferreira Juan CamiloChief Medical Officer07/18/202220,669
Arjona Ferreira Juan CamiloChief Medical Officer07/06/202236,917
Lang MatthewGeneral Counsel & Corp. Secy.07/06/202249,607
Arjona Ferreira Juan CamiloChief Medical Officer05/27/202213,917
Lang MatthewGeneral Counsel & Corp. Secy.04/19/202283,621
Arjona Ferreira Juan CamiloChief Medical Officer04/19/202248,404
Merendino LaurenChief Commercial Officer04/19/202273,662
Marek David CPrincipal Executive Officer04/19/2022257,007
Lang MatthewGeneral Counsel & Corp. Secy.04/05/202233,568
Arjona Ferreira Juan CamiloChief Medical Officer04/05/202226,485
Marek David CPrincipal Executive Officer01/19/2022291,868
Lang MatthewGeneral Counsel & Corp. Secy.01/04/202272,808
Arjona Ferreira Juan CamiloChief Medical Officer01/04/202236,949
Arjona Ferreira Juan CamiloChief Medical Officer11/29/202138,175
Arjona Ferreira Juan CamiloChief Medical Officer11/03/20215,446
Arjona Ferreira Juan CamiloChief Medical Officer11/04/202124,118
Arjona Ferreira Juan CamiloChief Medical Officer11/04/202174,462
Arjona Ferreira Juan CamiloChief Medical Officer11/03/202116,800
Arjona Ferreira Juan CamiloChief Medical Officer10/05/202159,196
Lang MatthewGeneral Counsel & Corp. Secy.10/05/2021144,227
Sumitomo Chemical Co., Ltd.10% Owner09/28/2021472,383
Arjona Ferreira Juan CamiloChief Medical Officer09/27/202154,460
Arjona Ferreira Juan CamiloChief Medical Officer09/27/2021170,240
Sumitomo Chemical Co., Ltd.10% Owner09/27/20211,162,390
Sumitomo Chemical Co., Ltd.10% Owner09/24/2021842,548
Sumitomo Chemical Co., Ltd.10% Owner09/22/20211,845,010
Sumitomo Chemical Co., Ltd.10% Owner09/23/20211,263,216
Sumitomo Chemical Co., Ltd.10% Owner09/21/2021966,451
Sumitomo Chemical Co., Ltd.10% Owner09/20/2021845,669
Sumitomo Chemical Co., Ltd.10% Owner09/17/2021864,105
Sumitomo Chemical Co., Ltd.10% Owner09/16/20211,087,550
Sumitomo Chemical Co., Ltd.10% Owner09/14/20211,575,686
Sumitomo Chemical Co., Ltd.10% Owner09/15/20211,975,489
Sumitomo Chemical Co., Ltd.10% Owner09/13/20211,945,049
Sumitomo Chemical Co., Ltd.10% Owner09/10/2021753,390
Curran TerrieDirector09/09/202137,103
Curran TerrieDirector09/09/2021124,063
Sumitomo Chemical Co., Ltd.10% Owner09/09/2021944,147
Sumitomo Chemical Co., Ltd.10% Owner09/08/2021563,663
Sumitomo Chemical Co., Ltd.10% Owner09/07/2021870,929
Sumitomo Chemical Co., Ltd.10% Owner09/03/2021834,994
Sumitomo Chemical Co., Ltd.10% Owner09/02/20211,645,893
Sumitomo Chemical Co., Ltd.10% Owner09/01/2021993,028
Curran TerrieDirector09/01/202187,003
Curran TerrieDirector09/02/2021284,083
Curran TerrieDirector09/01/2021284,325
Curran TerrieDirector09/02/2021929,489
Sumitomo Chemical Co., Ltd.10% Owner08/31/2021946,885
Sumitomo Chemical Co., Ltd.10% Owner08/30/20211,674,099
Arjona Ferreira Juan CamiloChief Medical Officer08/30/2021163,380
Arjona Ferreira Juan CamiloChief Medical Officer08/27/202144,881
Arjona Ferreira Juan CamiloChief Medical Officer08/30/2021505,050
Sumitomo Chemical Co., Ltd.10% Owner08/27/2021858,252
Sumitomo Chemical Co., Ltd.10% Owner08/26/2021906,912
Sumitomo Chemical Co., Ltd.10% Owner08/25/2021644,158
Sumitomo Chemical Co., Ltd.10% Owner08/24/2021767,269
Sumitomo Chemical Co., Ltd.10% Owner08/23/20211,236,736
Sumitomo Chemical Co., Ltd.10% Owner08/20/2021969,540
Sumitomo Chemical Co., Ltd.10% Owner08/19/20211,006,421
Sumitomo Chemical Co., Ltd.10% Owner08/18/2021367,092
Sumitomo Chemical Co., Ltd.10% Owner08/17/2021492,049
Sumitomo Chemical Co., Ltd.10% Owner08/16/20211,029,145
Lang MatthewGeneral Counsel & Corp. Secy.07/09/2021149,650
Arjona Ferreira Juan CamiloChief Medical Officer07/07/202160,400
KARBE FRANKPrincipal Fin'l & Accounting07/07/202170,296
Lang MatthewGeneral Counsel & Corp. Secy.04/06/2021202,250
KARBE FRANKPrincipal Fin'l & Accounting04/06/2021206,420
Arjona Ferreira Juan CamiloChief Medical Officer03/19/202154,460
Arjona Ferreira Juan CamiloChief Medical Officer03/19/2021169,190
Lang MatthewGeneral Counsel & Corp. Secy.03/15/2021233,400
Lang MatthewGeneral Counsel & Corp. Secy.03/15/2021752,013
Arjona Ferreira Juan CamiloChief Medical Officer03/01/202134,118
KARBE FRANKPrincipal Fin'l & Accounting02/16/20213,833
KARBE FRANKPrincipal Fin'l & Accounting02/16/202116,050
KARBE FRANKPrincipal Fin'l & Accounting01/28/20211,533
KARBE FRANKPrincipal Fin'l & Accounting01/28/20217,200
KARBE FRANKPrincipal Fin'l & Accounting01/15/20213,833
KARBE FRANKPrincipal Fin'l & Accounting01/15/202116,125
KARBE FRANKPrincipal Fin'l & Accounting12/28/202060,298
KARBE FRANKPrincipal Fin'l & Accounting12/28/2020354,000
Arjona Ferreira Juan CamiloChief Medical Officer12/18/202015,560
Arjona Ferreira Juan CamiloChief Medical Officer12/18/202052,000
Lang MatthewGeneral Counsel & Corp. Secy.12/18/202077,800
Lang MatthewGeneral Counsel & Corp. Secy.12/18/2020254,054
Arjona Ferreira Juan CamiloChief Medical Officer12/15/202054,460
Arjona Ferreira Juan CamiloChief Medical Officer12/15/2020167,426
KARBE FRANKPrincipal Fin'l & Accounting12/15/20205,366
KARBE FRANKPrincipal Fin'l & Accounting12/15/202025,363
Arjona Ferreira Juan CamiloChief Medical Officer12/10/202077,800
Arjona Ferreira Juan CamiloChief Medical Officer12/10/2020260,362
Lang MatthewGeneral Counsel & Corp. Secy.12/10/2020150,932
Lang MatthewGeneral Counsel & Corp. Secy.12/09/20204,668
Lang MatthewGeneral Counsel & Corp. Secy.12/09/202015,049
Lang MatthewGeneral Counsel & Corp. Secy.12/10/2020488,783
Arjona Ferreira Juan CamiloChief Medical Officer11/30/202046,780
KARBE FRANKPrincipal Fin'l & Accounting11/30/20207,665
KARBE FRANKPrincipal Fin'l & Accounting11/30/202036,000
KARBE FRANKPrincipal Fin'l & Accounting11/17/20203,833
KARBE FRANKPrincipal Fin'l & Accounting11/17/202015,000
Arjona Ferreira Juan CamiloChief Medical Officer11/17/202054,460
Arjona Ferreira Juan CamiloChief Medical Officer11/17/2020140,000
KARBE FRANKPrincipal Fin'l & Accounting11/13/20203,833
KARBE FRANKPrincipal Fin'l & Accounting11/13/202015,000
Arjona Ferreira Juan CamiloChief Medical Officer11/13/202054,460
Arjona Ferreira Juan CamiloChief Medical Officer11/13/2020140,000
KARBE FRANKPrincipal Fin'l & Accounting09/15/20203,833
KARBE FRANKPrincipal Fin'l & Accounting09/15/202016,297
Arjona Ferreira Juan CamiloChief Medical Officer09/15/202054,460
Arjona Ferreira Juan CamiloChief Medical Officer09/15/2020152,389
Lang MatthewGeneral Counsel & Corp. Secy.08/31/2020207,726
Lang MatthewGeneral Counsel & Corp. Secy.08/31/2020535,282
Arjona Ferreira Juan CamiloChief Medical Officer08/31/202087,968
Arjona Ferreira Juan CamiloChief Medical Officer08/31/2020226,197
KARBE FRANKPrincipal Fin'l & Accounting08/28/202018,652
KARBE FRANKPrincipal Fin'l & Accounting08/31/2020108,077
KARBE FRANKPrincipal Fin'l & Accounting08/31/2020423,275
KARBE FRANKPrincipal Fin'l & Accounting08/28/202073,146
Arjona Ferreira Juan CamiloChief Medical Officer08/28/202016,011
Arjona Ferreira Juan CamiloChief Medical Officer08/28/202041,181
Arjona Ferreira Juan CamiloChief Medical Officer08/27/2020133,273
Lang MatthewGeneral Counsel & Corp. Secy.08/26/2020778
Lang MatthewGeneral Counsel & Corp. Secy.08/28/202020,228
Lang MatthewGeneral Counsel & Corp. Secy.08/28/202052,052
Lang MatthewGeneral Counsel & Corp. Secy.08/26/20202,000
KARBE FRANKPrincipal Fin'l & Accounting08/19/20203,577
KARBE FRANKPrincipal Fin'l & Accounting08/19/202014,000
Lang MatthewGeneral Counsel & Corp. Secy.08/19/20204,668
Lang MatthewGeneral Counsel & Corp. Secy.08/19/202012,000
Arjona Ferreira Juan CamiloChief Medical Officer08/19/20204,940
Arjona Ferreira Juan CamiloChief Medical Officer08/19/202012,700
Arjona Ferreira Juan CamiloChief Medical Officer06/24/2020135,730
Arjona Ferreira Juan CamiloChief Medical Officer06/24/2020348,920
Arjona Ferreira Juan CamiloChief Medical Officer06/23/202031,540
Arjona Ferreira Juan CamiloChief Medical Officer06/23/202081,080
Sumitomo Chemical Co., Ltd.10% Owner05/19/2020605,050
Sumitomo Chemical Co., Ltd.10% Owner05/20/2020476,862
Sumitomo Chemical Co., Ltd.10% Owner05/18/2020432,624
Sumitomo Chemical Co., Ltd.10% Owner05/15/2020603,966
Sumitomo Chemical Co., Ltd.10% Owner05/14/2020600,760
Sumitomo Chemical Co., Ltd.10% Owner05/13/2020511,641
Sumitomo Chemical Co., Ltd.10% Owner05/12/2020330,405
Sumitomo Chemical Co., Ltd.10% Owner05/11/2020447,384
Sumitomo Chemical Co., Ltd.10% Owner05/06/2020612,075
Sumitomo Chemical Co., Ltd.10% Owner05/08/2020449,074
Sumitomo Chemical Co., Ltd.10% Owner05/07/2020442,137
Sumitomo Chemical Co., Ltd.10% Owner05/05/20201,196,540
Sumitomo Chemical Co., Ltd.10% Owner05/04/2020574,870
Sumitomo Chemical Co., Ltd.10% Owner05/01/2020569,180
Sumitomo Chemical Co., Ltd.10% Owner04/30/2020603,825
Sumitomo Chemical Co., Ltd.10% Owner04/29/2020595,895
Sumitomo Chemical Co., Ltd.10% Owner04/28/2020602,720
Sumitomo Chemical Co., Ltd.10% Owner04/27/2020493,302
Sumitomo Chemical Co., Ltd.10% Owner04/24/2020523,344
Sumitomo Chemical Co., Ltd.10% Owner04/23/2020432,103
Sumitomo Chemical Co., Ltd.10% Owner04/21/2020581,140
Sumitomo Chemical Co., Ltd.10% Owner04/22/2020596,730
Sumitomo Chemical Co., Ltd.10% Owner04/20/2020594,425
Sumitomo Chemical Co., Ltd.10% Owner04/17/2020753,536
Sumitomo Chemical Co., Ltd.10% Owner04/16/2020744,674
Sumitomo Chemical Co., Ltd.10% Owner04/15/2020733,698
Sumitomo Chemical Co., Ltd.10% Owner04/14/2020770,105
Sumitomo Chemical Co., Ltd.10% Owner04/13/2020686,546
Sumitomo Chemical Co., Ltd.10% Owner04/09/2020655,669
Sumitomo Chemical Co., Ltd.10% Owner04/08/2020596,939
Sumitomo Chemical Co., Ltd.10% Owner04/07/2020574,364
Sumitomo Chemical Co., Ltd.10% Owner04/06/2020590,520
Sumitomo Chemical Co., Ltd.10% Owner04/03/2020554,925
Sumitomo Chemical Co., Ltd.10% Owner04/01/2020522,298
Sumitomo Chemical Co., Ltd.10% Owner04/02/2020541,086
Sumitomo Chemical Co., Ltd.10% Owner03/31/2020557,984
Sumitomo Chemical Co., Ltd.10% Owner03/30/2020535,766
Sumitomo Chemical Co., Ltd.10% Owner03/27/2020558,250
Sumitomo Chemical Co., Ltd.10% Owner03/26/2020555,807
Sumitomo Chemical Co., Ltd.10% Owner03/25/2020821,895
Sumitomo Chemical Co., Ltd.10% Owner03/24/20201,620,559
Sumitomo Chemical Co., Ltd.10% Owner03/23/20201,621,931
Sumitomo Chemical Co., Ltd.10% Owner03/20/20201,472,709
Sumitomo Chemical Co., Ltd.10% Owner03/19/20201,488,958
Sumitomo Chemical Co., Ltd.10% Owner03/18/20201,434,938
Sablich KimChief Commercial Officer03/18/20205,787
Sumitomo Chemical Co., Ltd.10% Owner03/16/20201,406,008
Sumitomo Chemical Co., Ltd.10% Owner03/17/20201,433,949
Sablich KimChief Commercial Officer01/15/202067,954
Lang MatthewGeneral Counsel & Corp. Secy.12/30/2019295,730
KARBE FRANKPrincipal Fin'l & Accounting12/30/2019306,351
Sablich KimChief Commercial Officer12/18/201941,929
Roivant Sciences Ltd.10% Owner12/16/20192,572,206
Roivant Sciences Ltd.10% Owner12/17/20191,195,500
Roivant Sciences Ltd.10% Owner12/04/20191,279,315
Roivant Sciences Ltd.10% Owner12/02/20193,305,040
Roivant Sciences Ltd.10% Owner11/25/201952,500,000
Roivant Sciences Ltd.10% Owner11/21/20191,449,101
Roivant Sciences Ltd.10% Owner11/20/20191,572,587
Sebelius KathleenDirector06/12/201944,784
VIKING GLOBAL INVESTORS LP10% Owner06/04/201919,999,997
VIKING GLOBAL PERFORMANCE LLC10% Owner06/04/201919,999,997
KARBE FRANKPrincipal Fin'l & Accounting06/11/201972,800
QVT Associates GP LLC10% Owner06/04/201919,999,997
SVF Investments (UK) Ltd10% Owner06/04/201919,999,997
Machado Patrick10% Owner06/04/201919,999,997
Dexxon Holdings Ltd.10% Owner06/04/201919,999,997
Lo Andrew10% Owner06/04/201919,999,997
Roivant Sciences Ltd.10% Owner06/04/201919,999,997
Arjona Ferreira Juan CamiloChief Medical Officer02/15/20195,499
Altmeyer MarkDirector11/17/201746,830
VIKING GLOBAL INVESTORS LP10% Owner04/02/201822,500,005
VIKING GLOBAL PERFORMANCE LLC10% Owner04/02/201822,500,005
Dexxon Holdings Ltd.10% Owner04/02/201822,500,005
Lo Andrew10% Owner04/02/201822,500,005
SVF Investments (UK) Ltd10% Owner04/02/201822,500,005
Roivant Sciences Ltd.10% Owner04/02/201822,500,005
Machado Patrick10% Owner04/02/201822,500,005
QVT Associates GP LLCDirector04/02/201822,500,005
Takeda Pharmaceuticals International AG10% Owner03/19/2018138,543,069
Takeda Pharmaceuticals International AG10% Owner03/19/2018138,543,069
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2022
09/30/2022
0.37%
1Q
12/31/2022
06/30/2022
0.80%
2Q
12/31/2022
03/31/2022
3.42%
3Q
12/31/2022
12/31/2021
3.94%
4Q
12/31/2022
09/30/2021
4.49%
5Q
12/31/2022
06/30/2021
4.93%
6Q
12/31/2022
03/31/2021
6.80%
7Q
12/31/2022
12/31/2020
7.18%
8Q
12/31/2022
09/30/2020
7.41%
9Q
12/31/2022
06/30/2020
7.68%
10Q
12/31/2022
03/31/2020
12.02%
11Q
12/31/2022
12/31/2019
13.46%
12Q
12/31/2022
09/30/2019
16.32%
13Q
12/31/2022
06/30/2019
25.75%
14Q
12/31/2022
03/31/2019
43.71%
15Q
12/31/2022
12/31/2018
45.97%
16Q
Load More

Period of Report: 12/31/2022

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2022
0.37%
1Q
06/30/2022
0.80%
2Q
03/31/2022
3.42%
3Q
12/31/2021
3.94%
4Q
09/30/2021
4.49%
5Q
06/30/2021
4.93%
6Q
03/31/2021
6.80%
7Q
12/31/2020
7.18%
8Q
09/30/2020
7.41%
9Q
06/30/2020
7.68%
10Q
03/31/2020
12.02%
11Q
12/31/2019
13.46%
12Q
09/30/2019
16.32%
13Q
06/30/2019
25.75%
14Q
03/31/2019
43.71%
15Q
12/31/2018
45.97%
16Q
Load More